Drug Database
Back to search

France· FR:67503464

TRANSLARNA 125 mg, granulés pour suspension buvable

A ataluren product containing ataluren, registered in France by PTC THERAPEUTICS INTERNATIONAL (IRLANDE). The same ATC class is registered in 6 of our 19 countries.

ATC M09AX03

Checked against Base de données publique des médicaments — BDPM (France) on

Informational only — not a medical device.

SOURCE REGISTER · FRBase de données publique des médicament…normalisedTRANSLARNA 125 mg, granulés pour susp…ATCM09AX03REGISTER NO.FR:67503464PACKS LISTED1CHECKEDSeptember 12, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about atalurenAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Ataluren is registered in 6 of 19 countries.

Countries holding a registration under ATC M09AX03 (ataluren), each read from that country’s own register.

  • This record: France, from Base de données publique des médicaments — BDPM (France)
  • 4 of them publish a price we can compare per daily dose
Search ataluren products by name

Ataluren · ATC M09AX03

6 / 19 countries

  • Belgiumprice
  • Finlandprice
  • Franceprice
  • Ireland
  • Polandprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Base de données publique des médicaments — BDPM (France)
Active substance
ATALUREN
Manufacturer
PTC THERAPEUTICS INTERNATIONAL (IRLANDE)
Country
France (FR)
ATC code
M09AX03
ATC class
Ataluren
Defined daily dose
2.8 g, O
Reimbursed
No
Source register
Base de données publique des médicaments — BDPM (France)
Last checked
September 12, 2026

Packs & prices · 1

  • cip13
    3400927959141
    30 sachet(s) aluminium

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Ataluren in 6 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All ataluren products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/e404bdaa-998e-4b5f-974a-45406680e22b
GET /v1/drugs/e404bdaa-998e-4b5f-974a-45406680e22b?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "cis": "67503464",
  "date_amm": "2014-07-31",
  "type_amm": "Procédure centralisée",
  "numero_ue": "EU/1/13/902",
  "substance": "ATALUREN",
  "atc_source": "fr_atc_restore_2026-09-06",
  "statut_amm": "Autorisation archivée",
  "statut_bdm": "Alerte",
  "forme_pharmaceutique": "granulés pour suspension buvable",
  "voies_administration": "orale",
  "etat_commercialisation": "Non commercialisée",
  "surveillance_renforcee": "Non"
}
API referenceMCP serverPlans

See everything about ataluren.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console